Heart Failure (HF) : Warfarin Therapy Patients with Atrial Fibrillation (NQF 0084)

eMeasure Name Heart Failure (HF) : Warfarin Therapy Patients with Atrial Fibrillation eMeasure Id 9F157D15-A4BD-449C-BAFD-E67DBA5284DC
Version number 1 eMeasure Set Id E55B186F-DECC-4E7D-9D1A-ED5D7DCAFAF1
Available Date No information Measurement Period January 1, 20xx through December 31, 20xx
Measure Steward American Medical Association - Physician Consortium for Performance Improvement
Endorsed by National Quality Forum
Description Percentage of all patients aged 18 and older with a diagnosis of heart failure and paroxysmal or chronic atrial fibrillation who were prescribed warfarin therapy
Copyright
© 2010 American Medical Association. All Rights Reserved
Measure scoring Proportion
Measure type Process
Stratification
None
Risk Adjustment
None
Data Aggregation
Rationale
Adjusted-dose warfarin is highly efficacious in preventing thromboembolism in patients with AF and should be prescribed for all patients with AF and heart failure except those with contraindications to anticoagulation.
Clinical Recommendation Statement
Physicians should prescribe anticoagulants in patients with HF who have paroxysmal or persistent atrial fibrillation or a previous thromboembolic event (Class I, Level of Evidence: A).
Improvement notation
Higher score indicates better quality
Measurement duration
12 month(s)
Reference
Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline update for the diagnosis and management of chronic heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112:e154-e235.
Reference
Jessup M, Abraham WT, Mancini DM, et al.  DRAFT 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults:  a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines developed in Collaboration With the American Academy of Family Physicians, American College of Chest Physicians, Heart Failure Society of America, and International Society for Heart and Lung Transplantation (Writing Group to Review new evidence and update the 2005 guideline for the management of patients with chronic heart failure) developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung.
Definition
Initial Patient Population(s): 
Patient Age:  Patients aged 18 years and older at the beginning of the measurement period.
Diagnosis Active:  Patient has a documented diagnosis of heart failure. 
Encounter:  At least 2 visits with the physician, physician's assistant, or nurse practitioner during the measurement period.
Definition
Denominator(s): All patients aged 18 years and older with a diagnosis of heart failure and paroxysmal or chronic atrial fibrillation.
Definition
Denominator Exclusion(s): N/A
Definition
Numerator(s): Patients who were prescribed warfarin therapy.
Definition
Denominator Exception(s): 
Documentation of medical reason(s) for not prescribing warfarin therapy (eg, clinical contraindication, drug allergy, drug interaction, drug intolerance, other medical reason(s)).
Documentation of patient reason(s) for not prescribing warfarin therapy (eg, patient declined).
Documentation of system reason(s) for not prescribing warfarin therapy.
Guidance
Supplemental Data Elements
Report "Patient Characteristic: Gender" using "Gender HL7 Value Set (2.16.840.1.113883.1.11.1)"; Report "Patient Characteristic: Race" using "Race CDC Value Set (2.16.840.1.114222.4.11.836)"; Report "Patient Characteristic: Ethnicity" using "Ethnicity CDC Value Set (2.16.840.1.114222.4.11.837)"; Report "Patient Characteristic: Payer" using "Payer Source of Payment Typology Value Set (2.16.840.1.113883.3.221.5)".

Table of Contents


Population criteria

Data criteria (QDM Data Elements)

Supplemental Data Elements




Measure set CLINICAL QUALITY MEASURE SET 2011-2012